1. Home
  2. CRBU vs LEE Comparison

CRBU vs LEE Comparison

Compare CRBU & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.95

Market Cap

179.7M

Sector

Health Care

ML Signal

HOLD

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

HOLD

Current Price

$8.16

Market Cap

185.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRBU
LEE
Founded
2011
1890
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Newspapers/Magazines
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
179.7M
185.4M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
CRBU
LEE
Price
$1.95
$8.16
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$10.75
N/A
AVG Volume (30 Days)
1.3M
26.0K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
3.64
N/A
EPS
N/A
N/A
Revenue
N/A
$543,955,000.00
Revenue This Year
$1.63
$5.48
Revenue Next Year
$10.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$3.34
52 Week High
$3.53
$9.97

Technical Indicators

Market Signals
Indicator
CRBU
LEE
Relative Strength Index (RSI) 45.88 45.19
Support Level $1.70 $8.09
Resistance Level $2.06 $9.26
Average True Range (ATR) 0.12 0.45
MACD -0.04 -0.04
Stochastic Oscillator 19.64 16.00

Price Performance

Historical Comparison
CRBU
LEE

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks: